Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Regeneus Ltd. ( (AU:CMB) ) has shared an announcement.
Cambium Bio Limited has released its corporate governance statement for the financial year ending June 30, 2025, in compliance with ASX Listing Rules. The statement, available on their website, outlines the extent to which the company has adhered to the ASX Corporate Governance Council’s recommendations. This disclosure is crucial for stakeholders as it provides transparency regarding the company’s governance practices and any deviations from recommended guidelines, thereby impacting investor confidence and the company’s market positioning.
More about Regeneus Ltd.
Average Trading Volume: 15,262
Technical Sentiment Signal: Sell
Current Market Cap: A$8.04M
For a thorough assessment of CMB stock, go to TipRanks’ Stock Analysis page.